Computer-Aided Drug Discovery

InhibOx Completes Project For DormaTarg

Submitted by InhibOx on 19 December 2012 - 3:50pm

InhibOx recently completed a project for DormaTarg, Inc., based in Oklahoma City, OK, USA.  Their mission is to prevent the recurrence of cancer by identifying drugs that will destroy suppressed cancer cells before they re-activate, and are taking these lead compounds toward FDA approval.  DormaTarg is also seeking biomarkers of tumour dormancy.  Robert E. Hurst, PhD, President & CSO, DormaTarg, Inc., said:

InhibOx Joins the GO Fight Against Malaria (GO FAM) Project

Submitted by InhibOx on 12 July 2012 - 6:51pm

GO Fight Against MalariaResearchers at InhibOx and Prof.

Scopius-CSpace v6 new release – InhibOx’s leading 3D structure database of available chemicals just got 50% bigger

Submitted by InhibOx on 10 April 2012 - 2:06pm

Scopius, the world’s largest available curated 3D compound and fragment database, features enhanced cloud-enabled cheminformatics capabilities

InhibOx

Cloud-Enabled Drug Discovery

Cloud-Enabled Drug DiscoveryDrug discovery in the 21st century is undergoing the most dramatic change it has ever seen. Pharma companies are globalizing their R&D capabilities, seeking new collaboration partners and outsourcing activities from simple tasks to complete projects.  And everyone in pharma, biotechs, CROs and academic research institutes is seeking new and better approaches to discovering new drug candidates.

Syndicate content